Reconstituted High-Density Lipoprotein Attenuates Cholesterol Crystal-Induced Inflammatory Responses by Reducing...

Area of Science:

• Cardiovascular Science
• Immunology
• Biochemistry

Background:

• Atherosclerosis involves chronic arterial inflammation, with cholesterol crystals (CC) driving disease progression.
• The complement system is a key trigger of CC-induced inflammation via inflammasome activation.
• High-density lipoprotein (HDL) has cardioprotective effects, potentially linked to its anti-inflammatory properties.

Purpose of the Study:

• To investigate the impact of reconstituted HDL (rHDL) on CC-induced inflammation.
• To determine if rHDL can mitigate inflammatory responses triggered by cholesterol crystals in a human whole blood model.

Main Methods:

• Utilized a human whole blood model to assess CC-induced inflammation.
• Measured complement activation (C5b-9, C3c deposition) on CC surfaces.
• Quantified complement receptor 3 (CD11b/CD18) expression on immune cells.
• Assessed reactive oxygen species generation and pro-inflammatory cytokine release.

Main Results:

• rHDL effectively bound to CC, inhibiting complement activation and deposition.
• rHDL attenuated CC-induced expression of complement receptor 3 on monocytes and granulocytes.
• rHDL reduced reactive oxygen species generation and pro-inflammatory cytokine release triggered by CC.
• rHDL demonstrated significant anti-inflammatory effects in the presence of CC.

Conclusions:

• Cholesterol crystals are potent inducers of inflammation through complement system activation.
• rHDL exhibits a beneficial role in controlling CC-induced inflammatory responses.
• rHDL's ability to inhibit complement deposition on CC suggests a therapeutic potential in managing atherosclerosis.